Search

201. COVID-19: developing drugs and biological products for treatment or prevention

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, February 2021

Subject(s):

Biological Products
COVID-19 Drug Treatment
COVID-19 -- prevention & control
Drug Industry
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

202. COVID-19: efforts to increase vaccine availability and perspectives on initial implementation : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, April 2021

Subject(s):

COVID-19 -- economics
COVID-19 Vaccines -- supply & distribution
Government Regulation
United States

203. COVID-19: federal air marshal service should document its response to cases and facilitate access to testing : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, June 2021

Subject(s):

COVID-19 -- prevention & control
Government Regulation
Police -- statistics & numerical data
Travel-Related Illness
United States

204. COVID-19: federal efforts accelerate vaccine and therapeutic development, but more transparency needed on emergency use authorizations : report to Congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, November 2020

Subject(s):

COVID-19 Vaccines
Drug Approval
Drug Development
Disclosure
United States
United States. Department of Defense
United States. Department of Health and Human Services

205. COVID-19: federal efforts could be strengthened by timely and concerted actions : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, September 2020

Subject(s):

COVID-19 -- prevention & control
Pandemics -- prevention & control
Federal Government
United States

206. COVID-19: implementation and oversight of preparedness strategies at Veterans Affairs medical centers : report to Congressional addresses

Publication:

Washington, DC : United States Government Accountability Office, June 2021

Subject(s):

Civil Defense -- legislation & jurisprudence
COVID-19 -- prevention & control
Disaster Planning -- legislation & jurisprudence
Government Regulation
United States
United States. Department of Veterans Affairs

207. COVID-19: master protocols evaluating drugs and biological products for treatment or prevention

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2021

Subject(s):

Biological Products
Clinical Trial Protocols as Topic
COVID-19 Drug Treatment
COVID-19 -- prevention & control
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

208. COVID-19: opportunities to improve federal response and recovery efforts : report to the Congress

Publication:

Washington, DC : United States Government Accountability Office, June 2020

Subject(s):

COVID-19 -- economics
Government Regulation
Pandemics -- legislation & jurisprudence
United States

209. COVID-19: potency assay considerations for monoclonal antibodies and other therapeutic proteins targeting SARS-CoV-2 infectivity

Publication:

[Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021

Subject(s):

Antibodies, Monoclonal
COVID-19 Drug Treatment
Enzyme-Linked Immunosorbent Assay
SARS-CoV-2
Viral Plaque Assay
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

210. COVID-19: sustained federal action is crucial as pandemic enters its second year : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, March 2021

Subject(s):

COVID-19 -- economics
Disasters -- economics
Government Regulation
United States

211. COVID-19: urgent actions needed to better ensure an effective federal response : report to Congressional committees

Publication:

Washington, DC : United States Government Accountability Office, November 2020

Subject(s):

COVID-19 -- economics
Disaster Planning -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
United States

212. COVID-19: urgent federal actions to accelerate America's response

Publication:

Washington, D.C. : Bipartisan Policy Center, January 2021

Subject(s):

COVID-19 -- prevention & control
COVID-19 Testing
COVID-19 Vaccines -- supply & distribution
Healthcare Disparities
United States

213. Calculation of potential inflation-indexed rebates for Medicare Part B drugs

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017

Subject(s):

Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
United States
United States. Department of Health and Human Services

214. A call for federal action to improve nursing facilities

Author(s):

McEvoy, Kate, author
Milligan, Charles, author

Publication:

New York, NY : Milbank Memorial Fund, February 2022

Subject(s):

Nursing Homes
Quality Assurance, Health Care
Federal Government
United States
Centers for Medicare & Medicaid Services (U.S.)

215. Cancer clinical trial eligibility criteria: available therapy in non-curative settings

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2022

Subject(s):

Clinical Trials as Topic
Government Regulation
Neoplasms -- drug therapy
United States
United States. Food and Drug Administration

216. Cancer clinical trial eligibility criteria: brain metastases

Publication:

Silver Spring, MD : Food and Drug Administration, Oncology Center of Excellence, July 2020

Subject(s):

Brain Neoplasms
Clinical Trials as Topic
Eligibility Determination
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

217. Cancer clinical trial eligibility criteria: minimum age considerations for inclusion of pediatric patients : guidance for industry and IRBs

Publication:

Silver Spring, MD : United States Food and Drug Administration, Oncology Center of Excellence, July 2020

Subject(s):

Clinical Trials as Topic
Eligibility Determination
Neoplasms
Pediatrics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

218. Cancer clinical trial eligibility criteria: patients with HIV, hepatitis B Virus, or hepatitis C Virus Infections

Publication:

[Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020

Subject(s):

Clinical Trials as Topic
Hepatitis B
Hepatitis C
HIV
Neoplasms
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

219. Cancer clinical trial eligibility criteria: patients with organ dysfunction or prior or concurrent malignancies

Publication:

[Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020

Subject(s):

Clinical Trials as Topic
Eligibility Determination
Heart Failure
Liver Failure
Neoplasms
Renal Insufficiency
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

220. Cancer hospitalizations for Pennsylvania children

Publication:

Harrisburg, PA : Pennsylvania Health Care Cost Containment Council, September 2019

Subject(s):

Hospitalization -- statistics & numerical data
Neoplasms
Adolescent
Child
Pennsylvania
United States

221. Cannabis and cannabis-derived compounds: quality considerations for clinical research : guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, January 2023

Subject(s):

Cannabis
Drug Development
Government Regulation
Medical Marijuana
United States
United States. Food and Drug Administration

222. Care provider facilities described challenges addressing mental health needs of children in HHS custody

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2019

Subject(s):

Child Health Services
Emigrants and Immigrants -- psychology
Mental Health Services
Refugees
United States
United States. Department of Health and Human Services

223. Case study: Missouri’s efforts to protect children missing from foster care

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021

Subject(s):

Child, Foster -- legislation & jurisprudence
Foster Home Care -- legislation & jurisprudence
Government Regulation
Homeless Youth -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
Missouri
United States
United States. Department of Health and Human Services

224. Center for Devices and Radiological Health (CDRH) appeals processes: Guidance for industry and Food and Drug Administration staff

Publication:

[Silver Spring, MD] : Center for Devices and Radiological Health, March 2, 2022

Subject(s):

Device Approval -- legislation & jurisprudence
Dissent and Disputes
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

225. Center for Devices and Radiological Health (CDRH) appeals processes: questions and answers about 517A : guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, March 27, 2020

Subject(s):

Device Approval
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

226. Center for Devices and Radiological Health appeals processes: questions and answers about 517A : guidance for industry and Food and Drug Administration staff

Publication:

[Silver Spring, Maryland] : Center for Devices and Radiological Health, September 29, 2017

Subject(s):

Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

227. Centers For Disease Control and Prevention: use of special interest projects to fund prevention research centers : report to Congressional committees

Publication:

Washington, D.C. : U.S. Government Accountability Office, September 2017

Subject(s):

Preventive Health Services -- economics
Public Health
Research -- economics
United States
Centers for Disease Control and Prevention (U.S.)

228. Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

COVID-19
Government Regulation
Hispanic or Latino
Medicare
Telemedicine -- statistics & numerical data
Urban Population
United States

229. Certain ophthalmic products: policy regarding compliance with 21 CFR part 4

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, March 2022

Subject(s):

Administration, Ophthalmic
Equipment and Supplies
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

230. Certificates of confidentiality: guidance for sponsors, sponsor-investigators, researchers, industry, and food and drug administration staff

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research September 2020

Subject(s):

Biomedical Research
Confidentiality
Privacy
Research Subjects
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

231. Certified Community Behavioral Health Clinics demonstration program: report to Congress, 2020

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy, December 2021

Subject(s):

Community Mental Health Centers -- economics
Costs and Cost Analysis
Mental Health Services -- economics
Program Evaluation
Quality Indicators, Health Care
United States

232. Challenges appear to limit states' use of Medicaid payment suspensions

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017

Subject(s):

Fraud -- prevention & control
Medicaid -- economics
United States
United States. Department of Health and Human Services

233. Challenges remain in FDA's inspections of domestic food facilities

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017

Subject(s):

Food Industry
Food Inspection
Food Safety
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

234. Challenges to public health reporting experienced by non-federal acute care hospitals: 2019

Author(s):

Richwine, Chelsea, author
Marshall, Carmelita, author
Jensen, Christian, 1833-1916, author
Patel, Vaishali, author

Publication:

Washington, DC : U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology, September 2021

Subject(s):

Health Information Interoperability
Hospitals
Information Dissemination
Mandatory Reporting
Public Health
Public Health Surveillance
COVID-19
Health Facility Size
State Government
United States
United States. Department of Health and Human Services

235. Challenges with vaccination data hinder state and local immunization program efforts to combat COVID-19

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2023

Subject(s):

COVID-19 -- prevention & control
COVID-19 Vaccines
Data Accuracy
Data Analysis
Government Regulation
Immunization Programs
United States

236. Changes in health insurance coverage, 2019-2021: geographic and demographic patterns in the uninsured rate

Author(s):

Lee, Aiden, author
Ruhter, Joel, author
Bosworth, Arielle, author
Peters, Christie, author
De Lew, Nancy, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, January 2023

Subject(s):

Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Medically Uninsured -- statistics & numerical data
Ethnicity
Racial Groups
State Government
United States

237. Changes in home health care use in Medicare Advantage compared to traditional Medicare: 2011--2016

Author(s):

Zuckerman, Stephen, author
Skopec, Laura, author
Aarons, Joshua, author
Berenson, Robert A., author
Feder, Judith, author
Wissoker, Douglas, author
Huckfeldt, Peter J., author

Publication:

[Washington, D.C.] : United States Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy, September 2020

Subject(s):

Facilities and Services Utilization
Home Care Services
Medicare
Medicare Part C
United States

238. Changes in ownership of skilled nursing facilities from 2016 to 2021: variation by geographic location and quality

Author(s):

Oliveira, Iara, author
Blanco, Martin, (Of Office of Behavioral Health, Disability, and Aging Policy), author

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, July 7, 2022

Subject(s):

Ownership
Quality of Health Care -- statistics & numerical data
Skilled Nursing Facilities -- statistics & numerical data
Skilled Nursing Facilities -- trends
State Government
United States

239. Changes in service offerings post-system affiliation in rural hospitals

Author(s):

Oyeka, Onyinye, author
Ullrich, Fred, (Public health researcher) author
Shane, Dan, author
Mueller, Keith J., 1951- author

Publication:

Iowa City, IA : Rural Policy Research Institute, January 2023

Subject(s):

Hospitals, Rural -- organization & administration
Organizational Affiliation
Rural Health Services
United States

240. Changes in the list prices of prescription drugs, 2017-2023

Author(s):

Bosworth, Arielle, author
Sheingold, Steven, author
Finegold, Kenneth, author
Sayed, Bisma A., author
De Lew, Nancy, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, October 6, 2023

Subject(s):

Drug Costs -- trends
Prescription Drugs -- economics
United States

241. Changes to CBO's long-term Social Security projections since 2016

Publication:

[Washington, D.C.] : Congressional Budget Office, October 2017

Subject(s):

Social Security -- economics
Social Security -- trends
United States

242. Changes to existing medical software policies resulting from section 3060 of the 21st Century Cures Act: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, September 27, 2019

Subject(s):

Equipment and Supplies -- standards
Software -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.
United States.

243. Characteristics and challenges of rural ambulance agencies: a brief review and policy considerations

Author(s):

MacKinney, A. Clinton, author
Mueller, Keith J., author
Coburn, Andrew F., author
Knudson, Alana, author
Lundblad, Jeniffer P., author
McBride, Timothy D., author

Publication:

[Iowa City, Iowa] : Rural Policy Research Institute, January 2021

Subject(s):

Ambulances
Health Policy
Rural Health Services
Rural Population
United States

244. Characteristics of separated children in ORR’s care: June 27, 2018–November 15, 2020

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, November 2021

Subject(s):

Child Health -- legislation & jurisprudence
Government Regulation
Refugees -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

245. Charting the path forward for child care: using cost modeling to design new solutions

Author(s):

Aigner-Treworgy, Sam, author
Osborn, Caroline, (Of Early Childhood Initiative), author
Smith, Linda, (Of Early Childhood Initiative), author

Publication:

Washington, D.C. : Bipartisan Policy Center, November 2022

Subject(s):

Child Care -- economics
Child Day Care Centers -- economics
Models, Economic
United States

246. Chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs)

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, January 2020

Subject(s):

Chemistry, Pharmaceutical
Genetic Therapy
Investigational New Drug Application
Drugs, Investigational
Quality Control
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

247. Chemistry, manufacturing, and controls changes to an approved application: certain biological products

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2021

Subject(s):

Biological Products
Drug Approval
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

248. Child care industry trends during the recovery from the COVID-19 pandemic

Author(s):

Crouse, Gilbert, author
Ghertner, Robin, author
Chien, Nina, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Human Services Policy, January 2023

Subject(s):

Child Care -- trends
COVID-19 -- economics
Workforce -- trends
United States

249. Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress

Publication:

Washington, DC : United States Government Accountability Office, November 2017

Subject(s):

Child Welfare -- statistics & numerical data
Child Welfare -- trends
Health Policy
Interinstitutional Relations
Policy Making
Social Determinants of Health
United States

250. Child-resistant packaging statements in drug product labeling

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2019

Subject(s):

Consumer Product Safety
Drug Labeling -- standards
Drug Packaging -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration